This reprint aims to deepen our understanding of the connection between cardiovascular disease and endocrine/metabolic dysfunctions. It focuses on the impact of sex on the metabolic-cardiovascular burden and metabolic dysfunction-associated steatotic liver disease. Another aim of this reprint is to highlight the benefits of new therapeutic approaches in patients with associated endocrine and cardiovascular disease.